GNTA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

1 Analyst Rating

Wall Street analysts forecast GNTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNTA is 21.00 USD with a low forecast of 21.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.420

Low

21.00

Averages

21.00

High

21.00

Current: 1.420

Low

21.00

Averages

21.00

High

21.00

No data

Valuation Metrics

The current forward P/E ratio for Genenta Science SPA (GNTA.O) is -1.67, compared to its 5-year average forward P/E of -8.78. For a more detailed relative valuation and DCF analysis to assess Genenta Science SPA 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-8.78

Current PE

-1.67

Overvalued PE

-3.09

Undervalued PE

-14.48

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-4.93

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.33

Undervalued EV/EBITDA

-10.18

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

26.14

Current PS

0.00

Overvalued PS

85.86

Undervalued PS

-33.59

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

GNTA News & Events

Events Timeline

No data

News

2.0

12-15NASDAQ.COM

Market Update: Tilray Drives After-Hours Gains as Biotech Stocks Soar

2.0

11-24Newsfilter

Genenta Science Reports TEM-GBM Study Update, 44% 18-Month Survival Rate Achieved

9.5

11-20NASDAQ.COM

Earnings Growth Boosts PACS and Nutex; Zynex and Genenta Also Rise in After-Hours Trading

People Also Watch

Frequently Asked Questions

What is Genenta Science SPA (GNTA) stock price today?

The current price of GNTA is 1.42 USD — it has increased 0.71 % in the last trading day.

What is Genenta Science SPA (GNTA)'s business?

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

What is the price predicton of GNTA Stock?

What is Genenta Science SPA (GNTA)'s revenue for the last quarter?

Genenta Science SPA revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is Genenta Science SPA (GNTA)'s earnings per share (EPS) for the last quarter?

Genenta Science SPA. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for Genenta Science SPA (GNTA)'s fundamentals?

The market is revising No Change the revenue expectations for Genenta Science S.p.A. (GNTA) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -54.05%.

How many employees does Genenta Science SPA (GNTA). have?

Genenta Science SPA (GNTA) has 13 emplpoyees as of December 16 2025.

What is Genenta Science SPA (GNTA) market cap?

Today GNTA has the market capitalization of 33.27M USD.